This Week’s Biopharma News: FDA Commissioner Steps Down - Summary - MDSpire

This Week’s Biopharma News: FDA Commissioner Steps Down

Marty Makary’s resignation puts the agency under acting leadership, while BMS and Hengrui unveil a multibillion-dollar pipeline deal and GSK lines up a chronic hepatitis B launch in China.

  • May 19, 2026

  • 4 min

Share

Original Source(s)

This Week’s Biopharma News: FDA Commissioner Steps Down

  • May 19, 2026

Related Content

Three Trends Shaping Multi-omics Sample Preparation

Maximizing insight from limited samples, aligning data across molecular layers, and building consistency from the first step

Inflammatory Breast Cancer Biomarkers Found

Advanced RNA sequencing reveals fragments that distinguish the disease from other breast cancers

  • May 19, 2026

  • 2 min
This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min